Effect of portal vein embolisation on the growth rate of colorectal liver metastases

British Journal of Cancer

Volumn 100, Issue 4, 2009, Pages 617-622

  Pamecha, V ^a   Levene, A ^a   Grillo, F ^a   Woodward, N ^a   Dhillon, A ^a   Davidson, B R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Colorectal liver metastases; Liver resection; Portal vein embolisation

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MONOCLONAL ANTIBODY KI 67; OXALIPLATIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLASGOW COMA SCALE; GROWTH RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LIVER NECROSIS; LIVER RESECTION; MALE; MITOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN; PREOPERATIVE CARE; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; TUMOR VOLUME;

EID: 60349121016     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604872     Document Type: Article

References (26)

1. Abdalla EK, Hicks ME, Vauthey JN (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88: 165-175
2. Archer SG, Gray BN (1989) Vascularization of small liver metastases. Br J Surg 76: 545-548
3. Beal I, Anthony S, Papadopoulou A, Huthins R, Fusai K, Begent R, Tibballs J, Davidson BR (2006) The effect of chemotherapy in patients undergoing portal vein embolisation prior to hepatic resection for colorectal liver metastases. Br J Radiol 79(942): 473-478
4. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N (1988) Transforming growth factor beta mRNA increases during liver regeneration; a possible paracrinemechanism of growth regulation. Proc Natl Acad Sci USA 85: 1539-1543
5. Denys AL, Abehsera M, Leloutre B, Sauvanet A, Vilgrain V, O'Toole O, Belghiti J et al. (2000) Intrahepatic hemodynamic changes following portal vein embolization: a prospective Doppler study. Eur Radiol 10: 1703-1707
6. Dinant S, de Graaf W, Verwer BJ, Bennink RJ, van Lienden KP, Gouma DJ, van Vliet AK, van Gulik TM (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48: 685-692
7. Elias D, De Baere T, Roche A, Mducreux, Leclere J, Lasser P (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86: 784-788
8. Going JJ (1994) Efficiently estimated histologic cell counts. Hum Pathol 25(4): 333-336
9. Hurwitz HI, Fehrenbacher L, Hainsworth JD, Heim W, Berlin J, Holmgren E, Hambleton J, Novotny WF, Kabbinavar F (2005) Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer. J Clin Oncol 23: 3502
10. Kokudo N, Tada K, Seki M et al. (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34: 267-272
11. Kusaka K, Imamura H, Tomiya T, Takayama T, Makuuchi M (2006) Expression of transforming growth factor-alpha and -beta in hepatic lobes after hemihepatic portal vein embolization. Dig Dis Sci 51(8): 1404-1412. Epub 13 July 2006.
12. Melendez J, Ferri E, Zwillman M, Fischer M, DeMatteo R, Leung D, Jarnagin W, Fong Y, Blumgart LH (2001) Extended hepatic resection: a 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 192: 47-53
13. Mueller L, Grotelueschen R, Meyer J, Vashist YK, Abdulgawad A, Wilms C, Hillert C, Rogiers X, Broering DC (2003) Sustained function in atrophying liver tissue after portal branch ligation in the rat. J Surg Res 114: 146-155
14. Mueller L, Hillert C, Möller L, Krupski-Berdien G, Rogiers X, Broering DC (2008) Major hepatectomy for colorectal metastases: is preoperative portal occlusion an oncological risk factor? Ann Surg Oncol 15(7): 1908-1917
15. Nabeshima K, Shimano Y, Inoue T, Itoh H, Kataoka H, Koono M (1998) Hepatocyte growth factor/scatter factor induces not only scattering but also cohort migration of human colorectal adenocarcinoma cells. Int J Cancer 78: 750-759
16. Nagino M, Nimura Y, Kamiya J, Kanai M, Hayakawa N, Yamamoto H (1998) Immediate increase in arterial blood flow in embolized hepatic segments after portal vein embolization: CT demonstration. Am J Roentgenol 171: 1037-1039
17. Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD) (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371(9617): 1007-1016
18. Pamecha V, Glantzounis G, Davies N, Fusai G, Sharma D, Davidson B (2009) Long-Term Survival and Disease Recurrence Following Portal Vein Embolisation Prior to Major Hepatectomy for Colorectal Metastases. Ann Surg Oncol, 6 January 2009 [Epub ahead of print]
19. Peeters CF, de Waal RM, Wobbes T, Westphal JR, Ruers TJ (2006) Out growth of human liver metastases after resection of the primary colorectal tumour: a shift in the balance between apoptosis and proliferation. Int J Cancer 119(6): 1249-1253
20. Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzén F, Cassidy J (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 26(12): 2013-2019
21. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ (2005) Edinburgh Liver Surgery and Transplantation Experimental Research Group (eLISTER). The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54(2): 289-296
22. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M (2006) Surgical resection of hepatic metastases from colorectal cancer. Br J Cancer 94(7): 982-999
23. Uemura T, Miyazaki M, Hirai R, Matsumoto H, Ota T, Ohashi R, Shimizu N et al. (2000) Different expression of positive and negative regulators of hepatocyte growth in growing and shrinking hepatic lobes after portal vein branch ligation in rats. Int J Mol Med 5: 173-179
24. Ueno S, Aikou T, Tanabe G, Kobayashi Y, Hamanoue M, Mitsuse S, Kawaida K, Nakamura T (1996) Exogenous hepatocyte growth factor markedly stimulates liver regeneration following portal branch ligation in dogs. Cancer Chemother Pharmacol 38: 233-237
25. Weber JC, Nakano H, Bachellier P, Oussoultzoglou E, Inoue K, Shimura H, Wolf P, Chenard-Neu MP, Jaeck D (2001) Is a profileration index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg 182(1): 81-88
26. Yokoyama Y, Nagino M, Nimura Y (2007) Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 31(2): 367-374